BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 21333425)

  • 21. Conditions for coverage fail to relieve administrative burden.
    Wish D
    Nephrol News Issues; 2005 Sep; 19(10):46-7, 51. PubMed ID: 16187648
    [No Abstract]   [Full Text] [Related]  

  • 22. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 2009 proposed rule for prospective ESRD payment: perspectives from a for-profit small dialysis organization.
    Bhat JG; Bhat P
    Am J Kidney Dis; 2010 Feb; 55(2):231-3. PubMed ID: 20116686
    [No Abstract]   [Full Text] [Related]  

  • 24. The due diligence on the ESRD payment cut.
    Neumann ME
    Nephrol News Issues; 2013 Oct; 27(11):8. PubMed ID: 24288801
    [No Abstract]   [Full Text] [Related]  

  • 25. The 2009 proposed rule for prospective ESRD payment: perspectives from a not-for-profit small dialysis organization.
    Sadler JH
    Am J Kidney Dis; 2010 Feb; 55(2):229-30. PubMed ID: 20116685
    [No Abstract]   [Full Text] [Related]  

  • 26. Dissecting the bundle: The final rules for the prospective payment system for dialysis.
    Mayne T
    Nephrol News Issues; 2010 Sep; 24(10):14, 16, 18-9. PubMed ID: 20942326
    [No Abstract]   [Full Text] [Related]  

  • 27. The QIP: will it improve dialysis care? An overview.
    Fishbane S; Miller I; Danko H; Masani N
    Nephrol News Issues; 2012 Jan; 26(1):20, 22-4, 26. PubMed ID: 22359961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The changing tide in ESRD care.
    Sullivan JD
    Nephrol News Issues; 2010 Jul; 24(8):24, 27-8. PubMed ID: 20695319
    [No Abstract]   [Full Text] [Related]  

  • 29. Economic impact of case-mix adjusting the dialysis composite rate.
    Hirth RA; Roys EC; Wheeler JR; Messana JM; Turenne MN; Saran R; Pozniak AS; Wolfe RA
    J Am Soc Nephrol; 2005 May; 16(5):1172-6. PubMed ID: 15800122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bundled payment for ESRD--including ESAs in Medicare's dialysis package.
    Iglehart JK
    N Engl J Med; 2011 Feb; 364(7):593-5. PubMed ID: 21323538
    [No Abstract]   [Full Text] [Related]  

  • 31. Preparing for the bundle: one year later.
    Bhat P; Sokolowski W; Cundiff W; Bhat JG
    Nephrol News Issues; 2010 Jul; 24(8):30-2, 34-5. PubMed ID: 20695320
    [No Abstract]   [Full Text] [Related]  

  • 32. Is it time for Medicare to provide reimbursement for daily hemodialysis?
    Newmann JM
    Nephrol News Issues; 2001 Apr; 15(5):57-9. PubMed ID: 12108965
    [No Abstract]   [Full Text] [Related]  

  • 33. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
    Hornberger J; Hirth RA
    Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management.
    Hidai H
    Kidney Int; 2000 Jul; 58(1):363-73. PubMed ID: 10886583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The first DRG: lessons from the end stage renal disease program for the prospective payment system.
    Maxwell JH; Sapolsky HM
    Inquiry; 1987; 24(1):57-67. PubMed ID: 2951335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2009 proposed rule for prospective ESRD payment: perspectives from a large dialysis organization.
    Nissenson AR; Mayne TJ; Krishnan M
    Am J Kidney Dis; 2010 Feb; 55(2):223-6. PubMed ID: 20116683
    [No Abstract]   [Full Text] [Related]  

  • 37. Pediatric ESRD patients & their special treatment challenges.
    Cole BE
    Nephrol News Issues; 1989 Aug; 3(8):30-2. PubMed ID: 2674728
    [No Abstract]   [Full Text] [Related]  

  • 38. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
    Bhat P; Sokolowski W; Bhat JG
    Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges and directions for Medicare ESRD payment policy.
    Ray NF; Ross M
    Semin Nephrol; 2000 Nov; 20(6):565-76. PubMed ID: 11111858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.